These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26059930)

  • 21. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.
    Pereira S; Fontes F; Sonin T; Dias T; Fragoso M; Castro-Lopes JM; Lunet N
    Support Care Cancer; 2016 Apr; 24(4):1571-81. PubMed ID: 26384827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
    Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
    Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Supplements and Chemotherapy-Induced Peripheral Neuropathy: Hope or Hype?
    Ligibel JA
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 30053079
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.
    Gilchrist L
    Semin Pediatr Neurol; 2012 Mar; 19(1):9-17. PubMed ID: 22641071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
    Speck RM; Sammel MD; Farrar JT; Hennessy S; Mao JJ; Stineman MG; DeMichele A
    J Oncol Pract; 2013 Sep; 9(5):e234-40. PubMed ID: 23943894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
    Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
    Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.
    Tanay MA; Armes J
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13011. PubMed ID: 30790382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
    Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
    Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nursing care of chemotherapy-induced peripheral neuropathy].
    Hsu SY; Lu CH; Chen SZ; Jane SW
    Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.
    Ben-Horin I; Kahan P; Ryvo L; Inbar M; Lev-Ari S; Geva R
    Integr Cancer Ther; 2017 Sep; 16(3):258-262. PubMed ID: 28150504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.
    Binner M; Ross D; Browner I
    Oncol Nurs Forum; 2011 Jul; 38(4):448-54. PubMed ID: 21708535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
    Velasco R; Bruna J
    Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
    Han X; Wang L; Shi H; Zheng G; He J; Wu W; Shi J; Wei G; Zheng W; Sun J; Huang H; Cai Z
    BMC Cancer; 2017 Jan; 17(1):40. PubMed ID: 28068938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
    Eckhoff L; Knoop A; Jensen MB; Ewertz M
    Eur J Cancer; 2015 Feb; 51(3):292-300. PubMed ID: 25541155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy-induced peripheral neuropathy.
    Fehrenbacher JC
    Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy.
    Nudelman KN; McDonald BC; Wang Y; Smith DJ; West JD; O'Neill DP; Zanville NR; Champion VL; Schneider BP; Saykin AJ
    J Clin Oncol; 2016 Mar; 34(7):677-83. PubMed ID: 26527786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies.
    Youk J; Kim YS; Lim JA; Shin DY; Koh Y; Lee ST; Kim I
    PLoS One; 2017; 12(8):e0183491. PubMed ID: 28827818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.